Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
42
CCAP Quote, Financials, Valuation and Earnings
Last price:
$14.67
Seasonality move
:
-2.23%
Day range:
$14.47 - $14.71
52-week range:
$13.54 - $20.19
Dividend yield:
12.56%
P/E ratio:
10.93x
P/S ratio:
8.97x
P/B ratio:
0.75x
Volume:
194.2K
Avg. volume:
306.8K
1-year change:
-23.9%
Market cap:
$543M
Revenue:
$83.5M
EPS (TTM):
$1.34
Earnings Data
Next earnings date for CCAP
Aug 12
2025
Most recent earnings per share
$0.11
Missed by $0.42
(May 14/2025)
Consensus Estimate
$0.53
(May 14/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CCAP Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $42M | -- | -- | $0.46 | -- |
| 08/12/2025 | Q2 | $42.5M | -- | -- | $0.47 | -- |
| 05/14/2025 | Q1 | $45.1M | $7.1M | $0.11 | $0.53 | -$0.42 |
| 02/19/2025 | Q4 | $47.3M | $12.4M | $0.27 | $0.56 | -$0.29 |
| 11/11/2024 | Q3 | $48.9M | $18.1M | $0.41 | $0.58 | -$0.17 |
| 08/12/2024 | Q2 | $47.7M | $22.9M | $0.55 | $0.58 | -$0.03 |
| 05/08/2024 | Q1 | $47.7M | $30.1M | $0.76 | $0.58 | $0.18 |
| 02/21/2024 | Q4 | $47.7M | $33M | $0.84 | $0.57 | $0.27 |
| 11/08/2023 | Q3 | -- | -- | $0.61 | $0.56 | $0.05 |
| 08/09/2023 | Q2 | -- | -- | $0.61 | $0.55 | $0.06 |
| 05/10/2023 | Q1 | -- | -- | $0.24 | $0.46 | -$0.22 |
| 02/22/2023 | Q4 | -- | -- | $0.08 | $0.44 | -$0.36 |
| 11/09/2022 | Q3 | -- | -- | -$0.08 | $0.43 | -$0.51 |
| 08/10/2022 | Q2 | -- | -- | -$0.03 | $0.42 | -$0.45 |
| 05/09/2022 | Q1 | -- | -- | $0.52 | $0.41 | $0.11 |
| 02/23/2022 | Q4 | -- | -- | $0.43 | $0.41 | $0.02 |
| 11/10/2021 | Q3 | -- | -- | $0.59 | $0.42 | $0.18 |
| 08/11/2021 | Q2 | -- | -- | $1.16 | $0.45 | $0.71 |
| 05/12/2021 | Q1 | -- | -- | $0.76 | $0.48 | $0.28 |
| 02/24/2021 | Q4 | -- | -- | $1.22 | $0.46 | $0.76 |
| 11/04/2020 | Q3 | -- | -- | $1.36 | $0.48 | $0.88 |
| 08/10/2020 | Q2 | -- | -- | $2.00 | $0.44 | $1.56 |
| 05/12/2020 | Q1 | -- | -- | -$2.84 | $0.40 | -$3.24 |
| 03/04/2020 | Q4 | -- | -- | $0.31 | $0.48 | -$0.17 |
| 09/30/2019 | Q3 | -- | -- | $0.17 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | $0.54 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | $0.29 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$0.11 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | $0.16 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | $0.08 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | $0.09 | -- | -- |
Crescent Capital BDC Earnings Questions
-
How Much did Crescent Capital BDC Generate in Revenue Last Quarter?
Crescent Capital BDC reported $7.1M worth of top line sales in its most recent quarter.
-
Did Crescent Capital BDC Beat Earnings Last Quarter?
Crescent Capital BDC announced earnings per share of $0.11 which represents a miss of analyst forecast a $0.53 per share.
-
Is Crescent Capital BDC Profitable?
Crescent Capital BDC reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Crescent Capital BDC EPS Next Year?
Crescent Capital BDC's earnings are forecast to decrease from $1.99 per share to $2.41 per share next year representing a decrease of -8.34%.
-
When is Crescent Capital BDC's Earnings Date?
Crescent Capital BDC's next earnings date is August 12, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
